UChicago Leukemia Program
@UChicagoLeuk
Followers
537
Following
1K
Statuses
586
Twitter account run by the University of Chicago Leukemia Program. Tweets are not medical advice.
Chicago, IL
Joined December 2022
New article featuring Dr Larson and Dr Gurbuxani on ICC and WHO criteria in AML and treatment decisions
1
7
18
RT @Anand_88_Patel: Reminder about @HemeReports #ASH24 menin session on January 28th! Experts are @EuniceWangMD @jaltmanmd @GhayasIssa @Dr_…
0
8
0
check out @AyaOncologist giving ALL updates as part of this series!
🩸 The 2025 Highlights of ASH in North America is coming to Chicago in just two days! Don't miss out - register now to stay updated on the latest developments in hematological malignancies. @UChicagoLeuk @UChicagoHemOnc @UChicagoMed
0
0
4
new research featuring @DrWendyStock as co-author on a manuscript investigating FLT3-JMD mutations in AML!
0
0
8
Brand new review by @rafmadero Joseph Cannova and @myeloidmalig on imetelstat in lower-risk MDS!
0
1
3
high-impact research featuring @AyaOncologist as co-author re targeting CD74 in RUNX1-familial platelet disorder!
1
0
3
congrats to @mariamtn89 & Satyajit Kosuri for having one of the top-10 most-read articles in 2024 for @BloodAdvances
0
2
5
New research featuring @DrWendyStock looking at a mechanism of inotuzumab resistance in B-ALL!
0
0
3
Check out the @ic_MDS position paper on trial eligibility for patients with MDS featuring @myeloidmalig as co-author!
0
0
2
New publication alert! Check out this study led by @rafmadero @Anand_88_Patel looking at the impact of CD58 expression on InO efficacy in B-ALL! Other program members include @CanerSaygin @HJohnstonMD @AyaOncologist @DrWendyStock
0
7
21
RT @UCCancerCenter: 🩸 @UChicagoMed faculty and trainees presented ground breaking research and advancements in blood cancers at a recent #…
0
4
0
RT @UChicagoHemOnc: Congratulations to our Section Chief, Dr. @SoniSmithMD new electee to the @ASCO Board of Directors as the Designated Me…
0
6
0
check out this upcoming study led by @Anand_88_Patel @myeloidmalig looking at the combination of HMA +/- iadademstat in accelerated/blast-phase MPNs!
0
0
7
Hot-off-the-press paper in @BloodJournal on an early-phase study of HMA + VEN in higher-risk MDS featuring @myeloidmalig as co-author!
0
3
20
Brand view paper on a risk score for patients with AML getting HMA + VEN featuring @Anand_88_Patel @SamuelJYates @emdworkin & @MedChiefs resident Abigail Sneider!
0
1
10
Check out this poster summarizing a clinical trial of venetoclax with induction and consolidation with @Anand_88_Patel as senior author! #ASH24
1
3
10
RT @UCHemOncFellows: We're very excited to announce our class of incoming Hem/Onc fellows, the class of 2028! @UChicagoHemOnc
https://t.co…
0
5
0
